EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy

Giulia Marsili iD, Chiara Acchioni, Anna Lisa Remoli, Donatella Amatore, Rossella Sgarbanti, Marta De Angelis iD, Roberto Orsatti, Marta Acchioni, Andrea Astolfi iD, Nunzio Iraci iD, Simona Puzelli, Marzia Facchini und 9 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giulia Marsili und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Interferon Type I, Influenza, Human, Influenza A virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health- Istituto Superiore di Sanita' 2010, Istituto Superiore di Sanità, NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an urgent need to identify efficient antiviral compounds to combat existing and emerging RNA virus infections, particularly those related to seasonal and pandemic influenza outbreaks. While inhibitors of the influenza viral integral membrane proton channel protein (M2), neuraminidase (NA), and cap-dependent endonuclease are available, circulating influenza viruses acquire resistance over time. Thus, the need for the development of additional anti-influenza drugs with novel mechanisms of action exists. In the present study, a cell-based screening assay and a small molecule library were used to screen for activities that antagonized influenza A non-structural protein 1 (NS1), a highly conserved, multifunctional accessory protein that inhibits the type I interferon response against influenza. Two potential anti-influenza agents, compounds 157 and 164, were identified with anti-NS1 activity, resulting in the reduction of A/PR/8/34(H1N1) influenza A virus replication and the restoration of IFN-β expression in human lung epithelial A549 cells. A 3D pharmacophore modeling study of the active compounds provided a glimpse of the structural motifs that may contribute to anti-influenza virus activity. This screening approach is amenable to a broader analysis of small molecule compounds to inhibit other viral targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H1N1 SubtypeInterferon Type IInfluenza, HumanInfluenza A virusHumansViral Nonstructural ProteinsAntiviral AgentsVirus Replication

Stichwörter der Autor:innen

NS1diverse compound libraryinfluenza A virusesluciferase reporter assaypharmacophore modelingsmall molecule screeningtype I IFN

Substanzen

Interferon Type IViral Nonstructural ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
  • Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University, 00185 Rome, Italy.
  • Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  • Department of Pharmaceutical Sciences, Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
  • National Centre for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

ORCID-Profile: Giulia Marsili, Marta De Angelis, Andrea Astolfi, Nunzio Iraci, Stefano Sabatini, Fabiana Superti, Mariangela Agamennone, Maria Letizia Barreca, Lucia Nencioni, Marco Sgarbanti

Förderung

  • Italian Ministry of Health- Istituto Superiore di Sanita' 2010
  • Istituto Superiore di Sanità
  • NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
  • Italian Ministry of Health, Istituto Superiore di Sanita’ 2010
  • Sapienza Ateneo grants (LN) and EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
  • Italian Association for Cancer Research
  • European Union’s Horizon 2020 research and innovation programme
  • Marie Curie ITN INITIATE program

Zitieren

APA

Marsili, G., Acchioni, C., Remoli, A. L., Amatore, D., Sgarbanti, R., De Angelis, M., Orsatti, R., Acchioni, M., Astolfi, A., Iraci, N., Puzelli, S., Facchini, M., Perrotti, E., Cecchetti, V., Sabatini, S., Superti, F., Agamennone, M., Barreca, M. L., Hiscott, J., …, & Sgarbanti, M. (2023). Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310495

Vancouver

Marsili G, Acchioni C, Remoli AL, Amatore D, Sgarbanti R, De Angelis M, et al. Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310495

BibTeX
@article{Marsili2023,
  author = {Marsili, Giulia and Acchioni, Chiara and Remoli, Anna Lisa and Amatore, Donatella and Sgarbanti, Rossella and De Angelis, Marta and Orsatti, Roberto and Acchioni, Marta and Astolfi, Andrea and Iraci, Nunzio and Puzelli, Simona and Facchini, Marzia and Perrotti, Edvige and Cecchetti, Violetta and Sabatini, Stefano and Superti, Fabiana and Agamennone, Mariangela and Barreca, Maria Letizia and Hiscott, John and Nencioni, Lucia and Sgarbanti, Marco},
  title = {Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310495}
}
Kostenlos starten →